Portfolio AOP Health Austria
A Product overview with focus on Rare Diseases.
AOP Health's focus is on integrated therapies for rare diseases and in critical care. The portfolio comprises products in the following therapeutic areas: Hemato-oncology, Cardiology & Pulmonology, Neurology and Metabolic Disorders and Critical Care. AOP Health’s strategic goal is to constantly deliver new treatment options with respect to rare diseases and critical care.
BESREMi® is indicated as monotherapy in adults for the treatment of Polycythaemia vera without symptomatic splenomegaly.
Canemes® can prevent nausea and vomiting in patients undergoing chemotherapy for malignant tumours and is used if other drugs do not have the desired effect.